Teladoc Stock News

Teladoc Health Inc. (NYSE:TDOC) traded at $101.74 at last check on Monday, November 29, made a downward move of -7.18% on its previous days price. Looking at the stock we see that its previous close was $109.61 and the beta (5Y monthly) reads 0.22 with the days price range being $109.06 $119.98. In terms Teladoc Health Inc. (NYSE: TDOC) Analysts Revisions Point To Positive Sentiment Read More »

Islay Capital Management LLC raised its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 9.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,305 shares of the health services providers stock after purchasing an additional 115 shares during []

Teladoc Health Inc. (NYSE:TDOC) has a beta value of 0.30 and has seen 5.69 million shares traded in the last trading session. The company, currently valued at $18.60B, closed the last trade at $109.61 per share which meant it gained $3.61 on the day or 3.41% during that session. The TDOC stock price is -181.0% … Why Do Investors Buy Stock In Teladoc Health Inc. (TDOC)? Read More »

Inovio Pharmaceuticals, Inc. (INO) with the stream of 4.77% also noticed, India Teladoc Health, Inc. (TDOC) encountered a rapid change of 3.41% in the last hour of trading session. Inovio The post Highly Unusual Volume Spikes: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Teladoc Health, Inc. (NYSE:TDOC) appeared first on Stocks Equity .

Equities research analysts expect Teladoc Health, Inc. (NYSE:TDOC) to post $543.47 million in sales for the current quarter, Zacks reports. Nine analysts have provided estimates for Teladoc Healths earnings. The highest sales estimate is $548.86 million and the lowest is $540.30 million. Teladoc Health posted sales of $383.32 million in the same quarter last year, []

Teladoc Health (NYSE:TDOC) had its price objective cut by Canaccord Genuity from $188.00 to $160.00 in a research report report published on Tuesday, The Fly reports. They currently have a buy rating on the health services providers stock. Several other equities research analysts also recently weighed in on TDOC. Oppenheimer decreased their price target on []

Wall Street brokerages expect that Teladoc Health, Inc. (NYSE:TDOC) will report sales of $543.47 million for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have made estimates for Teladoc Healths earnings, with the lowest sales estimate coming in at $540.30 million and the highest estimate coming in at $548.86 million. Teladoc Health []

NEW YORK , Nov. 26, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VIR, BNTX, CARS, TDOC, and PFE. Full story available on Benzinga.com

Analysts expect Teladoc Health, Inc. (NYSE:TDOC) to post sales of $543.47 million for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have made estimates for Teladoc Healths earnings, with the lowest sales estimate coming in at $540.30 million and the highest estimate coming in at $548.86 million. Teladoc Health reported sales of $383.32 []

NEW YORK , Nov. 24, 2021 /PRNewswire/ -- It''s no secret that the ongoing global pandemic is taking a toll on mental health, but few realize how much it is affecting children, up until recently, that is. Last month, a coalition of America''s leading experts in pediatric health declared a mental health crisis among children that is quickly escalating into a national emergency. The declaration calls on policymakers to make access to telemedicine and mental health care in schools a priority. Fortunately, the Biden Administration has pledged to provide nearly $85 million for mental health awareness, training, and treatment for children. The Canadian Liberal has also said previously that it will give provinces and territories $4.5 billion over five years in targeted funding for mental health. As governments turn their attention to funding, companies like Mednow Inc. (TSXV: MNOW ) (OTCQB: MDNWF ), Teladoc Health Inc. (NYSE: TDOC ), CloudMD Software & Services Inc. (TSXV: DOC ) (OTCPK:DOCRF), 1Life Healthcare, Inc . (NASDAQ: ONEM ), and Well Health Technologies Corp . (TSX: WELL ) (OTCPK:WLYYF) continue bolstering their virtual mental health offerings to meet the growing market need.

Don''t Look Now, But Cathie Wood''s Ark Is Taking On Water Among the biggest losers over the last 48 hour tech stock volatility has beenwell, everything in Cathie Wood''s "flagship" ARKK portfolio. Ergo, Wood''s ARKK fund has continued its dismal year, looking as though it could be heading back toward double digits any day now. Key components of Cathie Wood''s ARKK fund, including Tesla, Zoom, Spotify and DraftKings, are all lower in trading on Tuesday. Tesla is down more than 5% and names like Spotify and DraftKings were also down more than 5% at their lows during the cash session. Astute observers online are also starting to point out what can only be described as a massively widening delta between ARKK and all major indexes - to the tune of a whopping 40%! How long can investors ignore numbers like these from their favorite "active manager" before funds begin a deluge out of the way of all things Cathie Wood? $ARKK -16% YTD $QQQ +26% YTD $SPY +25% YTD DR. LUCID (@DRLUCID520) November 23, 2021 In addition, Wood''s Ark Genomic Revolution ETF has also been suffering outflows in November as returns lag.

Teladoc Health (NYSE:TDOC) had its price objective reduced by analysts at Canaccord Genuity from $188.00 to $160.00 in a research report issued on Tuesday, The Fly reports. The brokerage presently has a buy rating on the health services providers stock. Canaccord Genuitys price objective points to a potential upside of 46.68% from the stocks previous []

Li Auto Inc. (LI) with the stream of 2.12% also noticed, India Teladoc Health, Inc. (TDOC) encountered a rapid change of -6.08% in the last hour of Mondays trading session. The post Analysts Report Recap: Li Auto Inc. (NASDAQ:LI), Teladoc Health, Inc. (NYSE:TDOC) appeared first on Stocks Equity .

BTIG Research lowered shares of Teladoc Health (NYSE:TDOC) from a buy rating to a neutral rating in a research note released on Monday, Price Targets.com reports. Other research analysts also recently issued research reports about the stock. Argus downgraded shares of Teladoc Health from a buy rating to a hold rating in a report on []